2004 patent
Anti-cryptosporidium parvum preparations
Washington, DC: U.S. Patent and Trademark Office.
2004 patent
Neutralization-sensitive epitopes of Cryptosporidium parvum
Washington, DC: U.S. Patent and Trademark Office.
2002 journal article
Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 46(2), 275–282.
2001 patent
Neutralization-sensitive epitopes of Cryptosporidium parvum
Washington, DC: U.S. Patent and Trademark Office.
2001 journal article
Targeted disruption of CSL ligand-host cell receptor interaction in treatment of Cryptosporidium parvum infection
Journal of Eukaryotic Microbiology, (2001), 44S–46.
2000 patent
Anti-Cryptosporidium parvum preparations
Washington, DC: U.S. Patent and Trademark Office.
2000 chapter
Detection of mucosally delivered antibody to Cryptosporidium parvum p23 in infected calves
In K. M. K. J. A. House & E. P. J. Gibbs (Eds.), Tropical veterinary diseases: Control and prevention in the context of the new world order (Vol. 916, pp. 378–387). New York, NY: New York Academy of Sciences.
Ed(s): K. J. A. House & E. Gibbs
2000 journal article
Excretion patterns of mucosally delivered antibodies to p23 in Cryptosporidium parvum infected calves
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 76(3-4), 309–317.
2000 journal article
Primary immunodeficiencies of horses
VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE, 16(1), 105-+.
1999 journal article
Cryptosporidium parvum sporozoite pellicle antigen recognized by a neutralizing monoclonal antibody is a beta-mannosylated glycolipid
Infection and Immunity, 67(3), 1317–1322.
1999 journal article
Detection of equine antibodies to Babesia Caballi by recombinant B-Caballi Rhoptry-associated protein 1 in a competitive-Inhibition enzyme-linked immunosorbent assay
Journal of Clinical Microbiology, 37(7), 2285–2290.
1999 journal article
Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein
VACCINE, 17(17), 2142–2149.
1998 journal article
CD8 dimer usage on alpha beta and gamma delta T lymphocytes from equine lymphoid tissues
IMMUNOBIOLOGY, 198(4), 424–438.
1998 journal article
Equine SCID: mechanistic analysis and comparison with murine SCID
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 65(1), 1–9.
1998 journal article
IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: Analysis of CD4(+)alpha beta+IFN-gamma(+) and CD4(+)alpha beta+IL-4(+) lymphocytes in gut-associated lymphoid tissue during resolution of infection
Journal of Immunology, 161(4), 1891–1900.
1997 journal article
A kinase-negative mutation of DNA-PK(CS) in equine scid results in defective coding and signal joint formation
Journal of Immunology, 158(8), 3565–3569.
1997 journal article
Activation of intestinal intraepithelial T lymphocytes in calves infected with Cryptosporidium parvum
Infection and Immunity, 65(1), 185–190.
1997 journal article
Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies
VIROLOGY, 230(2), 275–280.
1997 journal article
Evaluation of a test for identification of Arabian horses heterozygous for the severe combined immunodeficiency trait
Journal of the American Veterinary Medical Association, 211(10), 1268-.
1997 journal article
Genetic and biochemical analysis of erythrocyte-stage surface antigens belonging to a family of highly conserved proteins of Babesia equi and Theileria species
Molecular and Biochemical Parasitology, 90(1), 69–79.
1996 journal article
A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 80(2), 137–147.
Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.
Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.